002433.SZ Stock Analysis
00
Uncovered
Guangdong Taiantang Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Guangdong Taiantang Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of medicines; the planting, processing and sale of Chinese herbal medicines; and the pharmaceutical e-commerce business. The company is headquartered in Shantou, Guangdong and currently employs 1,271 full-time employees. The company went IPO on 2010-06-18. The firm operates five segments. Chinese Patent Medicines Manufacturing Business segment is mainly responsible for the production and wholesale of Pibao cream, Qilin pill, Xinbao pill, Xinxin pill, Tongqiao Yixin pill, etc. Primary Processing Business segment of the traditional Chinese medicine materials is mainly responsible for planting, primary processing and sales of the ginseng and traditional Chinese medicine materials. Drug Wholesale and Retail Business segment is mainly responsible for the wholesale and retail of drugs and medical devices. Health Industry Development and Products Sales segment is mainly responsible for the development and sales of health concept real estate products. Medical Services segment is mainly responsible for the in-depth development of medical and elderly care services.